Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Issuer Symbol
-
SNDX on Nasdaq
Keith A. Goldan - trading volume in the past year for Syndax Pharmaceuticals Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
140,429 |
$2,952,941 |
$21.03 |
09 Feb 2026 |
Direct |
|
|
| Stock Options (Right to buy) |
118,000 |
$2,410,740 |
$20.43 |
04 Feb 2026 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.